Literature DB >> 8977756

Undiagnosed morbidity in adult women with Turner's syndrome.

A S Garden1, M J Diver, W D Fraser.   

Abstract

OBJECTIVE: Adult patients with Turner's syndrome are rarely followed up at specialist clinics after discharge from paediatric care but do have a predisposition to several long-term medical problems. We have assessed the undiagnosed morbidity that exists among adult women with Turner's syndrome. PATIENTS: A group of 32 women (age range 17-52 years; mean 25 years) attending a specialist out-patient clinic. MEASUREMENTS: Blood samples were obtained at the initial visit for lipid assessment, thyroid function, gonadal status and routine biochemical profile. Bone mineral density (BMD) was measured in 31 of the women.
RESULTS: Thirty-one women were receiving some form of oestrogen replacement. Two were receiving T4 therapy. In 50%, total cholesterol was greater than 5.2 mmol/l (range 3.4-9.3 mmol/l, mean 5.8 mmol/l) and 28% had an abnormality of thyroid function tests. Two women were newly diagnosed as hypothyroid, 6 had compensated hypothyroidism and one was under-replaced with T4. Lumbar spine BMD was below 100% of age matched reference range in 84% and below 75% in 26% of patients. Femoral neck BMD was below 100% of age matched reference range in 90% and below 75% in 10% of patients.
CONCLUSIONS: There is a high incidence of undiagnosed lipid, thyroid and bone mineral density abnormalities in the adult population with Turner's syndrome. Doctors caring for these women need to be aware of and look for the potential problems. Appropriate long-term treatment should be commenced to help prevent the development of lipid, skeletal and thyroid abnormalities which may cause these patients major problems in the future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977756     DOI: 10.1046/j.1365-2265.1996.00849.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Atherogenic lipid profile and systolic blood pressure are associated with carotid artery intima-media thickness in children with Turner syndrome.

Authors:  Özgür Pirgon; Mehmet Emre Atabek; Bülent Oran; Rıdvan Güçlü
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-11-02

Review 3.  Fracture risk and bone mineral density in Turner syndrome.

Authors:  Vladimir K Bakalov; Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2008-04-15       Impact factor: 6.514

4.  Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism.

Authors:  M Wojcik; D Janus; A Zygmunt-Gorska; J B Starzyk
Journal:  J Endocrinol Invest       Date:  2014-10-11       Impact factor: 4.256

5.  Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome.

Authors:  Francisco Álvarez-Nava; Marcia Racines; Julia Witt; Jéssica Guarderas; María Estévez; Roberto Lanes
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-09       Impact factor: 3.168

6.  Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.

Authors:  Hitoshi Kohno; Yutaka Igarashi; Keiichi Ozono; Kenji Ohyama; Masamichi Ogawa; Hisao Osada; Kazumichi Onigata; Susumu Kanzaki; Yoshiki Seino; Hiroaki Takahashi; Toshihiro Tajima; Katsuhiko Tachibana; Hiroyuki Tanaka; Yoshikazu Nishi; Tomonobu Hasegawa; Kenji Fujieda; Keinosuke Fujita; Reiko Horikawa; Susumu Yokoya; Toru Yorifuji; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2012-03-24

Review 7.  Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.

Authors:  Meenal Mavinkurve; Clodagh S O'Gorman
Journal:  BBA Clin       Date:  2015-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.